Trial · NCT07908615
Office Hysteroscopy Versus Operating-room Hysteroscopy for Uterine Lesions
NCT07908615, Not applicable, Not yet recruiting, Nantes University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Office Hysteroscopy Versus Operating-room Hysteroscopy for Uterine Lesions. Trials, record NCT07908615. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908615
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Office Hysteroscopy Versus Operating-room Hysteroscopy for Uterine Lesions
- NCT number
- NCT07908615
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 474 participants, estimated
- Lead sponsor
- Nantes University Hospital
- Conditions
- Uterine Polyps, Uterine Fibroids, Retained Products of Conception
- Interventions
- Operating-room hysteroscopy with resectoscope, Outpatient hysteroscopic morcellation/aspiration
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incremental cost-utility ratio of outpatient hysteroscopic morcellation/aspiration versus operating-room resectoscopy | Six months after inclusion | Cost-utility analysis comparing the two care pathways from a collective perspective. Costs and quality-adjusted life years (QALYs) derived from EQ-5D-5L measurements will be compared between groups. The incremental cost-utility ratio will be expressed as cost per QALY and results will also be presented as incremental net monetary benefit at different willingness-to-pay thresholds. |
| Secondary | Five-year budget impact of national adoption of outpatient hysteroscopic morcellation/aspiration | Five-year time horizon | Estimated financial impact for the French National Health Insurance system under scenarios of national adoption of outpatient hysteroscopic morcellation/aspiration instead of operating-room resectoscopy. |
| Secondary | Completeness of the operative hysteroscopy procedure | At the end of the procedure | Presence of a residual lesion identified by the surgeon at the end of the procedure. |
| Secondary | Duration of the operative hysteroscopy procedure | During the procedure | Time in minutes from insertion of the hysteroscope into the cervical canal to completion of the operative procedure, marked by the final removal of the hysteroscope. |
| Secondary | Intraoperative complications | During the operative procedure | Occurrence of complications including uterine perforation, procedure interruption for any reason, conversion to another technique, or other procedure-related complications specified in the protocol. |
| Secondary | Pain intensity and analgesic use | During and at the end of the procedure, immediately after surgery, and at Day 7 after the intervention | Pain assessed using a numerical rating scale and additional analgesic use. For the resectoscope group, immediate postoperative pain is assessed 30 minutes after awakening, with a ±30-minute window. |
| Secondary | Change in symptoms and disease-specific quality of life | At inclusion; Day 7, Month 1 and Month 12 after intervention; and Months 3 and 6 after inclusion | Symptoms assessed using the Higham score and disease-specific quality of life assessed using the UFS-QoL questionnaire, at the time points specified in the protocol. |
| Secondary | Health-related quality of life measured using EQ-5D-5L | At inclusion and at Months 3 and 6 after inclusion | Health-related quality of life measured using the EQ-5D-5L questionnaire to estimate QALYs for the cost-utility analysis. |
| Secondary | Need for further treatment or repeat intervention | At Months 1 and 12 after intervention, and Months 3 and 6 after inclusion | Proportion of participants requiring further treatment or repeat intervention at the time points specified in the protocol. |
| Secondary | Time to treatment, hospital length of stay and healthcare resource use | From inclusion through the follow-up period, as applicable | Time from inclusion to intervention, hospital length of stay, healthcare consumption and analgesic use after the procedure. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908615
GET https://conductscience.org/api/trials/v1/NCT07908615/registered